Conference Call to be Hosted on Monday, January 12 at 1:30 PM PT/4:30 PM ET FREMONT, CA / ACCESS Newswire / January 8, 2026 / Tivic Health® Systems, Inc. (Nasdaq:TIVC), a late-stage immunotherapeutics company, today announced that Management will host a special conference call to further discuss the company's recent acquisition of certain contract development and manufacturing organization (CDMO) assets as announced on December 11, 2025. The call will cover how the acquisition has accelerated key strategic priorities and development and commercialization timelines, as well as discuss other near-term potential benefits. WHO: Jennifer Ernst, Chief Executive Officer of Tivic Michael K. Handley, Chief Operating Officer of Tivic and President of Tivic Biopharma WHEN: Monday, January 12, 2026 -1:30 PM Pacific Time / 4:30 PM Eastern Time Questions can be submitted in advance to [email protected].